COVID-19 trials registries data warehouse

https://anzctr.org.au/ACTRN12621001372875.aspx

Abdus Shakoor

shakoorma@bsmmu.edu.bd

2021-10-11

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

• Nasopharyngeal swab samples (tested by RT-PCR) positive for the COVID-19. • Subjects Aged 15 years or more of all genders. • O2 saturation as measured by pulse oximetry (SpO2) greater than 90 % in room air. • Patients having symptoms mild to moderate in nature • A resting respiratory rate 30/m or less than 30/m. • Able to realize the content of questionnaires and who will provide consent.

• Subjects aged more than 70 years of all genders. • Subjects having severe form of COVID-19 • Subjects having severe COPD bronchial asthma and severe ischemic heart disease. .• Chronic liver and kidney disease • Pregnant or lactating women • Patients admitted in ICU

2

Bangabandhu Sheikh Mujib Medical University (BSMMU)

15

70

Bangladesh

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

100

Difficulty in breathing will be assessed by using Modified Medical Research Council (MMRC) scale.[At the first attendance (week one) with week 2; 3 and 4 ( primary time point) post-enrolment. ]

Not reported

[{"arm_notes": "", "treatment_id": 230, "treatment_name": "Breathing exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]